医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

幹細胞

Wipro Partners with Transcell Oncologics to Transform Vaccine Safety Assessment

Wipro Partners with Transcell Oncologics to Transform Vaccine Safety Assessment

バイオテクノロジーヘルスケアヘルス一般幹細胞感染症製薬　 TimeLine: Wipro Partners with Transcell Oncologics to Transform Vaccine Safety Assessment

2021年05月05日

Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion

Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion

その他ヘルスバイオテクノロジーヘルスケア医療機器幹細胞感染症病院臨床試験　 TimeLine: Initial COVID Organicell Announces Positive Results Patient Trial in India and Trial Expansion Zofin

2021年04月28日

Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem® for Acute Respiratory Distress Syndrome in Japan

Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem® for Acute Respiratory Distress Syndrome in Japan

その他ヘルスバイオテクノロジーヘルスケア幹細胞臨床試験　 TimeLine: Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem for Acute Respiratory Distress Syndrome in Japan

2021年03月31日

Celltrion Healthcare receives positive CHMP opinion for subcutaneous formulation of infliximab, Remsima® SC, for direct use of subcutaneous therapy without IV loading in adults with rheumatoid arthritis

Celltrion Healthcare receives positive CHMP opinion for subcutaneous formulation of infliximab, Remsima® SC, for direct use of subcutaneous therapy without IV loading in adults with rheumatoid arthritis

バイオテクノロジーヘルスケア医療機器幹細胞製薬　 TimeLine: Celltrion Healthcare Receives Positive CHMP IV loading Remsima SC therapy without

2021年03月31日

Genetron Health to Present at Science/AAAS Webinar About Early Cancer Screening on March 31

Genetron Health to Present at Science/AAAS Webinar About Early Cancer Screening on March 31

バイオテクノロジーヘルスケア幹細胞腫瘍学製薬　 TimeLine: AAAS Webinar About Early Cancer Screening on March 31 Genetron Health to Present at Science

2021年03月15日

ヒアルロン酸が豊富な軟骨細胞培養に3次元組織工学プラットフォームで成功―軟骨再生治療の新たな一歩

ヒアルロン酸が豊富な軟骨細胞培養に3次元組織工学プラットフォームで成功―軟骨再生治療の新たな一歩

バイオテクノロジーヘルスケア外科幹細胞病院　 TimeLine: 3次元組織工学プラットフォームヒアルロン酸成功軟骨再生治療軟骨細胞培養

2021年03月11日

软骨再生细胞疗法在3D组织工程平台中通过富含透明质酸的软骨细胞得到增强

软骨再生细胞疗法在3D组织工程平台中通过富含透明质酸的软骨细胞得到增强

バイオテクノロジーヘルスケア外科幹細胞病院　 TimeLine: 软骨再生细胞疗法在3D组织工程平台中通过富含透明质酸的软骨细胞得到增强

2021年03月10日

Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry During the Week of Rare Disease Day 2021

Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry During the Week of Rare Disease Day 2021

バイオテクノロジーヘルスケア医療機器幹細胞感染症腫瘍学臨床試験製薬遺伝学　 TimeLine: FDA Approval of Nulibry During the Week of Rare Disease Day 2021 Veristat Congratulates Origin Biosciences for

2021年03月08日

Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platform

Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platform

バイオテクノロジーヘルスケア外科幹細胞病院　 TimeLine: Cell Therapy for Cartilage Regeneration Gets a Boost With Hyaluronic Acid Enriched Chondrocytes in a 3D Tissue Engineering Platform

2021年03月08日